We are live on ! Find out more
NA

Navellier & Associates Portfolio holdings

AUM $1.26B
1-Year Est. Return 95.39%
This Fund
S&P 500
This Quarter Est. Return
-12.81%
1 Year Est. Return
+95.39%
3 Year Est. Return
+360.87%
5 Year Est. Return
+519.82%
10 Year Est. Return
+3,025.57%
AUM
$466M
AUM Growth
-$122M
Cap. Flow
-$33.7M
Cap. Flow %
-7.23%
Top 10 Hldgs %
19.61%
Holding
343
New
56
Increased
75
Reduced
115
Closed
70

Sector Composition

Rank Sector Weight
1 Energy 19.17%
2 Technology 14.02%
3 Consumer Staples 13.84%
4 Industrials 12.99%
5 Materials 10.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$5.17T
$16.5M 3.54%
1,088,220
-24,650
-2% -$465K
COP icon
2
ConocoPhillips
COP
$159B
$11.3M 2.42%
125,413
+1,482
+1% +$153K
EOG icon
3
EOG Resources
EOG
$76B
$10.2M 2.19%
92,502
+20,701
+29% +$2.57M
BG icon
4
Bunge Global
BG
$22.5B
$9.88M 2.12%
108,979
+104,540
+2,355% +$11.6M
ADM icon
5
Archer Daniels Midland
ADM
$41B
$9.08M 1.95%
117,041
+111,691
+2,088% +$9.76M
CF icon
6
CF Industries
CF
$20B
$9.04M 1.94%
105,511
+54,525
+107% +$5.3M
CUBE icon
7
CubeSmart
CUBE
$8.94B
$6.95M 1.49%
162,710
+3,240
+2% +$149K
COST icon
8
Costco
COST
$396B
$6.56M 1.41%
13,689
+12,997
+1,878% +$6.59M
COKE icon
9
Coca-Cola Consolidated
COKE
$13.2B
$6.02M 1.29%
106,750
-6,370
-6% -$333K
LLY icon
10
Eli Lilly
LLY
$1.01T
$5.83M 1.25%
+17,974
New +$5.4M
AMN icon
11
AMN Healthcare
AMN
$1.35B
$5.73M 1.23%
52,207
-35,902
-41% -$3.55M
TSN icon
12
Tyson Foods
TSN
$18.3B
$5.55M 1.19%
64,493
-1,302
-2% -$117K
DVN icon
13
Devon Energy
DVN
$53.3B
$5.45M 1.17%
98,898
+565
+0.6% +$36.9K
CHH icon
14
Choice Hotels
CHH
$4.42B
$5.41M 1.16%
48,423
-2,491
-5% -$323K
FXH icon
15
First Trust Health Care AlphaDEX Fund
FXH
$1.14B
$5.36M 1.15%
+52,000
New +$5.6M
MRO
16
DELISTED
Marathon Oil Corporation
MRO
$5.36M 1.15%
238,316
+1,123
+0.5% +$30K
UMC icon
17
United Microelectronic
UMC
$56.5B
$5.26M 1.13%
776,701
-17,349
-2% -$142K
FXG icon
18
First Trust Consumer Staples AlphaDEX Fund
FXG
$219M
$5.2M 1.12%
84,804
-6,807
-7% -$436K
EXR icon
19
Extra Space Storage
EXR
$28.8B
$5.17M 1.11%
30,363
-614
-2% -$114K
FXN icon
20
First Trust Energy AlphaDEX Fund
FXN
$392M
$5.1M 1.09%
345,379
-52,006
-13% -$844K
FTNT icon
21
Fortinet
FTNT
$126B
$5.07M 1.09%
89,615
-56,815
-39% -$3.37M
FXR icon
22
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$702M
$4.98M 1.07%
103,488
+7,642
+8% +$402K
PWR icon
23
Quanta Services
PWR
$93.1B
$4.97M 1.07%
39,656
-495
-1% -$60.8K
FXD icon
24
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$248M
$4.86M 1.04%
108,730
+10,139
+10% +$507K
UVV icon
25
Universal Corp
UVV
$1.11B
$4.86M 1.04%
80,255
+4,520
+6% +$270K

Similar funds

Navellier & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Navellier & Associates held 343 positions worth $466M, down 21% from $588M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Navellier & Associates withdrew a net $33.7M in Q2 2022, closing 70 positions and reducing 115 holdings. Its most notable exit was West Pharmaceutical, an estimated $16.9M position sold in full.

By sector, the portfolio is most concentrated in Energy at 19% of assets, up from 11% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Navellier & Associates opened a new position in First Trust Health Care AlphaDEX Fund worth $5.36M.

  • Navellier & Associates's largest Q2 2022 buy was First Trust Health Care AlphaDEX Fund: 52,000 shares worth $5.36M.
  • Navellier & Associates added most to Bunge Global in Q2 2022, an estimated $11.6M increase.
  • Navellier & Associates's biggest Q2 2022 reduction was AMN Healthcare, cutting an estimated $3.55M.
  • Navellier & Associates fully exited West Pharmaceutical in Q2 2022, selling an estimated $16.9M.
  • Navellier & Associates's ten largest holdings make up 20% of its $466M portfolio in Q2 2022.
  • Navellier & Associates opened 56 new positions and closed 70 in Q2 2022.
  • Navellier & Associates's portfolio value fell 21% quarter-over-quarter to $466M.

Based on Navellier & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.